The Human Antibody Fragment DIATHIS1 Specific for CEACAM1 Enhances Natural Killer Cell Cytotoxicity Against Melanoma Cell Lines In Vitro
| Autor: | Dupuis, Maria L, Fiori, Valentina, Soriani, Alessandra, Ricci, Biancamaria, Dominici, Sabrina, Moricoli, Diego, Ascione, Alessandro, Santoni, Angela, Magnani, Mauro, Cianfriglia, Maurizio, Dupuis, Fiori and Soriani contributed equally to this work |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2015 |
| Předmět: |
Cancer Research
Antigens CD Cell Adhesion Molecules Cell Line Tumor Humans Immunotherapy Killer Cells Natural Antibody-Dependent Cell Cytotoxicity Melanoma Single-Chain Antibodies Immunology Basic Studies NK cells Biology Major histocompatibility complex Natural killer cell Cell Line Interleukin 21 scFv antibodies medicine melanoma Immunology and Allergy Killer Cells Antigens CEACAM1 Pharmacology Lymphokine-activated killer cell Tumor Degranulation Natural killer T cell Molecular biology CD medicine.anatomical_structure Cell culture biology.protein Cancer research Interleukin 12 Natural ComputingMethodologies_DOCUMENTANDTEXTPROCESSING immunotherapy |
| Zdroj: | Journal of Immunotherapy (Hagerstown, Md. : 1997) Scopus-Elsevier |
| Popis: | Supplemental Digital Content is available in the text. Several lines of evidence show that de novo expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is strongly associated with reduced disease-free survival of patients affected by metastatic melanoma. Previously published investigations report that homophilic interactions between CEACAM1 expressed on natural killer (NK) cells and tumors inhibit the NK cell-mediated killing independently of major histocompatibility complex class I recognition. This biological property can be physiologically relevant in metastatic melanoma because of the increased CEACAM1 expression observed on NK cells from some patients. Moreover, this inhibitory mechanism in many cases might hinder the efficacy of immunotherapeutic treatments of CEACAM1+ malignancies because of tumor evasion by activated effector cells. In the present study, we designed an in vitro experimental model showing that the human single-chain variable fragment (scFv) DIATHIS1 specific for CEACAM1 is able to enhance the lytic machinery of NK cells against CEACAM1+ melanoma cells. The coincubation of the scFv DIATHIS1 with CEACAM1+ melanoma cells and NK-92 cell line significantly increases the cell-mediated cytotoxicity. Moreover, pretreatment of melanoma cells with scFv DIATHIS1 promotes the activation and the degranulation capacity of in vitro–expanded NK cells from healthy donors. It is interesting to note that the melanoma cell line MelC and the primary melanoma cells STA that respond better to DIATHIS1 treatment, express higher relative levels of CEACAM1-3L and CEACAM1-3S splice variants isoforms compared with Mel501 cells that are less responsive to DIATHIS1-induced NK cell–mediated cytotoxicity. Taken together, our results suggest that the fully human antibody fragment DIATHIS1 originated by biopanning approach from a phage antibody library may represent a relevant biotechnological platform to design and develop completely human antimelanoma therapeutics of biological origin. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|